Proyectos de ley › 89.ª Asamblea General
Relating to prescription refills in emergency situations and insurance coverage for prescription insulin
Dónde está ahora
- Hecho: Presentado23 de febrero de 2022
- Se detuvo: SubcomitéMurió al terminar la Asamblea General
- Sigue: Comité de la Cámara
- Sigue: Lo aprueba la Cámara
- Sigue: Comité del Senado
- Sigue: Lo aprueba el Senado
- Sigue: A gobernador(a)
- Sigue: Firmado como ley
Murió al terminar la sesión La sesión de 2022 terminó el 24 de mayo de 2022, la última sesión ordinaria de la Asamblea General. Los proyectos que no pasaron por ambas cámaras murieron. ¿Qué es el embudo (funnel)?
Qué contiene
Resumen con IA Pharmacists can use their professional judgment to provide a one-time emergency refill of up to a 30-day supply of medicine for a patient. Additionally, health insurance plans must limit how much a person pays out-of-pocket for certain types of insulin. For a 31-day supply of these insulin drugs, the cost to the person cannot be more than $25. (Todavía no está traducido al español.)1
Lea la explicación oficial (en inglés)
This bill relates to prescription refills in emergency situations and insurance coverage for prescription insulin drugs. The bill allows a pharmacist to exercise professional judgment and refill a prescription once in a 12-month period and to dispense an amount not to exceed a 30-day supply, or if the standard amount of dispensing exceeds a 30-day supply or is unit dosed, an amount not to exceed the standard supply or limit of dispensing. The bill requires a policy, contract, or plan providing for third-party payment or prepayment of health or medical expenses that provides coverage for prescription drugs to cap the total amount of cost-sharing that a covered person is required to pay per prescription filled to an amount not to exceed $25 for up to a 31-day supply of at least one type of each of rapid-acting prescription insulin drugs, short-acting prescription insulin drugs, intermediate-acting prescription insulin drugs, or long-acting prescription insulin drugs. “Prescription insulin drug” is defined in the bill as a prescription drug that contains insulin, is used to treat diabetes, has been prescribed as medically necessary by a covered person’s health care professional, and is a benefit covered by a covered person’s policy, contract, or plan. The bill defines “cost-sharing” as any coverage limit, copayment, coinsurance, deductible, or other out-of-pocket expense imposed on a covered person. A policy, contract, or plan is not prohibited from providing for third-party payment or prepayment of health or medical expenses from reducing a covered person’s cost-sharing to less than $25 for a 31-day supply of a prescription insulin drug. This section of the bill applies to third-party payment provider contracts, policies, or plans delivered, issued for delivery, continued, or renewed in this state on or after January 1, 2023, by the third-party payment providers enumerated in the bill. The types of specialized health-related insurance which are not subject to the coverage requirements are specified in the bill. The commissioner of insurance may adopt rules to administer the requirements of this section of the bill.
Lo que cambia del Código de Iowa (Iowa Code)
Crea§514C.18A
Modifica§155A.29
Cabildeo
1 a favor · 0 en contra · 0 indecisos · Quiénes →
Tried before
This idea has been filed in an earlier General Assembly. None became law, though one got through a chamber.
- HF 2138 Relating to insurance coverage for prescription insulin drugs88th General Assembly · Passed House · similarPassed a chamber
Similar bills this General Assembly
- HF 263 Relating to insurance coverage for prescription insulin drugs, and including applicability…89th General Assembly · Passed HouseVery similar
- HF 405 Relating to insurance coverage for prescription insulin drugs91st General Assembly · In committeeSimilar
- HF 658 Relating to insurance coverage for prescription insulin drugs91st General Assembly · In committeeSimilar
- SF 2047 Relating to insurance coverage for prescription insulin drugs91st General Assembly · In committeeSimilar
- HF 502 Relating to insurance coverage for prescription insulin drugs90th General Assembly · In committeeSimilar
- HF 694 Relating to insurance coverage for prescription insulin drugs90th General Assembly · In committeeSimilar
- SF 2062 Relating to insurance coverage for prescription insulin drugs90th General Assembly · In committeeSimilar
- SF 2322 Relating to insurance coverage for prescription insulin drugs91st General Assembly · In committeeSimilar
- SF 2214 Relating to insurance coverage for prescription insulin drugs90th General Assembly · Approved by committeeSimilar
Matched by wording or an identical title.